Akèy › Limfom Difize Gwo Selil B › South Dakota
Etid klinik pou Limfom Difize Gwo Selil B nan South Dakota
3 etid pou Limfom Difize Gwo Selil B ap chèche patisipan nan sit nan South Dakota.
Vil nan South Dakota
Tèks ofisyèl etid la (Anglè)
Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL
- Avera Cancer Institute, Sioux Falls
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT06500273A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)
- Sanford Cancer Center ( Site 0143), Sioux Falls
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT06717347Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
- Sanford Children's Hospital-Sanford Children's Specialty Clinic ( Site 1015), Sioux Falls
Ap rekriteFaz 1/2
6 Months – 25 Years · Tout sèks · Mizajou Sep 17, 2026 · NCT06395103Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.